1.Identify key therapy areas/ products/ complex generics/ sole FTF/ 505b2 opportunities for US/ EU/ ROW/ India markets.
2.Identify and monitor progress of potential current critical care products while in Phase II and Phase III clinical trials for addition to pipeline
3.Make Business Case for identified products. Liason with RND/ Clinical/ RA/ API team/ IP/ marketing etc. and compile relevant information.
4.Present shortlisted products to senior management for addition to company pipeline, with objectives of achieving business target and building potential for sustained revenue growth
5.Track industry news/ investor presentations/ IMS/ New approvals/ FTF's/ citizen petition opportunities etc. and appraise the relevant team members. Track novel NDA's for existing molecules